echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > A new therapeutic strategy for on-demand and cell-autonomous genes that can stop seizures in mice | selected by Science One Week

    A new therapeutic strategy for on-demand and cell-autonomous genes that can stop seizures in mice | selected by Science One Week

    • Last Update: 2022-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Click on the blue words above to follow us


    The researchers report that a gene that can be expressed as needed to inhibit neuronal activity offers a new way to
    reduce spontaneous seizures in mice.


    In a new study, Yichen Qiu and colleagues introduced a closed-loop gene therapy for diseases of brain circuits in which only a subset of neurons is pathologically overactive
    .
    Spontaneous and intermittent seizures are characteristic of neurodevelopmental and neuropsychiatric disorders
    such as epilepsy.

    Although these seizures can be reduced by using anti-epileptic drugs, nearly one-third of people with epilepsy do not respond to
    these treatments.
    Others respond well initially, but they later develop resistance
    .


    Beyond drug solutions, some gene therapy strategies have shown promise
    .
    However, these methods tend to indiscriminately target all neurons in specific brain regions, rather than those specific brain circuits that are problematic in connection with triggering seizures
    .


    To solve this problem, Qui et al.
    developed a gene therapy strategy that selects pathologically overresponsive neurons on its own and down-regulates their excitability
    in a closed-loop feedback system.
    This method uses the Fos gene, whose expression can
    be upregulated by neuronal activity, including epilepsy, to control the Kcna1 gene, which encodes a suppressor gene that calms
    neuronal activity.


    Qiu et al.
    transfected neurons
    in a mouse model of epilepsy using adeno-associated viral vectors encoding the Fos promoter and Kcna1.
    During intense neuronal activity, Fos promotes the expression of Kcna1, but this increase in expression occurs only in overactive neurons, and only when
    these neurons appear to be abnormally active.


    These findings suggest that neuronal excitability in these cells is inhibited by epilepsy-related activity, and as such, it provides a persistent anti-epileptic effect
    that does not interfere with normal behavior.


    Welcome to pay attention to the official scientific public account

    Click "Read Original" below to access the original English article

    Light up your likes for this issue of Science

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.